Then, we tested the alteration of PI3K-Akt pathways and HDACs in ESCC cell lines after CUDC-907 treatment to confirm the results above (Additional file 1: Fig. S3a, b). This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.